{"gene":"MATN3","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2005,"finding":"MED-causing MATN3 mutations in the A-domain cause misfolding of that domain (shown by unfolded conformation of mutant A-domains expressed individually) and prevent secretion of matrilin-3 from mammalian cells; mutant protein is retained intracellularly. Co-immunoprecipitation demonstrated that mutant A-domains associate specifically with ERp72, an ER chaperone involved in disulfide bond formation. Electron microscopy of patient cartilage confirmed intracellular retention in dilated rough ER cisternae.","method":"Mammalian cell expression of wild-type and mutant matrilin-3, co-immunoprecipitation with ERp72, electron microscopy and immunohistochemistry of patient cartilage","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, multiple orthogonal methods (cell secretion assay, structural analysis of isolated domain, EM of patient tissue), replicated in subsequent studies","pmids":["16287128"],"is_preprint":false},{"year":2007,"finding":"In a knock-in mouse model carrying a Matn3 MED mutation, mutant matrilin-3 is retained within the rough ER of chondrocytes and triggers an unfolded protein response (UPR), leading to decreased chondrocyte proliferation and spatially dysregulated apoptosis in the cartilage growth plate, which disrupts linear bone growth and causes short-limbed dwarfism.","method":"Mouse knock-in model, histochemistry, immunohistochemistry, electron microscopy, assessment of chondrocyte proliferation and apoptosis in growth plate","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knock-in model with multiple orthogonal cellular readouts (UPR, proliferation, apoptosis), consistent with in vitro findings from multiple labs","pmids":["17517694"],"is_preprint":false},{"year":2008,"finding":"Two alpha-helical A-domain mutations (p.Phe105Ser and p.Ala173Asp) prevent secretion of matrilin-3 A-domain in vitro, similar to beta-sheet mutations. However, a third alpha-helical mutation (p.Lys231Asn) does not prevent A-domain secretion, does not disrupt A-domain structure, and does not inhibit binding to type II or type IX collagen, leaving its disease mechanism unresolved.","method":"In vitro A-domain expression and secretion assay, structural assessment, collagen binding assay","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single lab, multiple assays (secretion, structural, collagen binding), clear positive and negative findings distinguished","pmids":["18205203"],"is_preprint":false},{"year":2012,"finding":"Secretion of mutant matrilin-3 (V194D) is not dependent on hetero-oligomerization with matrilin-1; ablation of matrilin-1 expression in Matn3 V194D mice does not alter the proportion of mutant matrilin-3 in the ECM, does not increase intracellular retention, and does not worsen disease severity. Retained mutant matrilin-3 forms non-native disulfide-bonded aggregates through the misfolded A-domain and causes co-retention of matrilin-1.","method":"Genetic cross of Matn3 V194D knock-in with Matn1-null mice; histochemistry, biochemistry (disulfide-bonded aggregate analysis), phenotypic assessment","journal":"Arthritis and rheumatism","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo double-mutant genetic epistasis, biochemical characterization of aggregates, multiple orthogonal methods, clear negative and positive findings","pmids":["22083516"],"is_preprint":false},{"year":1998,"finding":"Human MATN3 encodes a 486 amino acid extracellular matrix protein with the domain architecture: signal peptide, von Willebrand factor A (vWFA) domain, four EGF repeats, and an alpha-helical coiled-coil region. The mRNA is expressed in all cartilage types and by primary (but not dedifferentiated) chondrocytes, suggesting matrilin-3 as a marker of chondrocyte differentiation state.","method":"cDNA cloning from cartilage library, sequence analysis, Northern blot / expression in primary vs. dedifferentiated chondrocytes","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — structural characterization from cDNA, cell biology of expression in differentiation states; foundational characterization paper","pmids":["9799608"],"is_preprint":false},{"year":2000,"finding":"The mouse Matn3 gene comprises 8 exons spanning 23.4 kb; the last intron uses non-canonical AT-AC ends and is spliced by the U12-type spliceosome, a feature conserved in all matrilin genes. Unlike other matrilins, Matn3 lacks a second vWFA domain; the intron that could encode it contains 75% repetitive sequences indicating evolutionary loss.","method":"Genomic cloning, exon mapping, RNase protection assay for transcription start sites, SSCP mapping","journal":"Mammalian genome","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct genomic and structural characterization, single lab, well-defined methods","pmids":["10656920"],"is_preprint":false},{"year":2004,"finding":"All characterized MED-causing MATN3 mutations cluster within exon 2 encoding the vWFA (A) domain, specifically in and around the 2nd beta-sheet region (amino acids 120-127). One novel mutation (p.F105S) extends the affected region to an alpha-helix of the A-domain, outside the beta-sheet.","method":"PCR and direct sequencing of all 8 MATN3 exons in MED patients","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — mutation mapping by sequencing in multiple unrelated families, consistent with parallel studies, but no functional assay in this paper","pmids":["15459972"],"is_preprint":false},{"year":2018,"finding":"An intragenic de novo tandem duplication of exons 2–5 in MATN3 (formed via Alu-Alu mediated recombination) causes multiple epiphyseal dysplasia, establishing intragenic CNV as a novel mutational mechanism for MATN3-related disease.","method":"Targeted CNV screening, breakpoint characterization (Alu-Alu fusion identification)","journal":"Human mutation","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single case, structural/genetic characterization only, no functional assay for MATN3 protein","pmids":["30080953"],"is_preprint":false},{"year":2021,"finding":"Exosomal MATN3 protein from urine-derived stem cells promotes nucleus pulposus cell (NPC) proliferation and ECM synthesis, and alleviates intervertebral disc degeneration in vivo. The mechanism involves MATN3 activating TGF-β signaling, elevating phosphorylation of SMAD and AKT. MATN3 was identified as the required cargo mediating these USC-exosome effects by knockdown experiments.","method":"Western blot, CCK-8 proliferation assay, immunofluorescence, in vivo IDD mouse model (CT, MRI, histology), MATN3 knockdown in exosomes","journal":"Oxidative medicine and cellular longevity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single lab, multiple orthogonal methods (in vitro knockdown, in vivo rescue), defined signaling readout (SMAD/AKT phosphorylation)","pmids":["34136064"],"is_preprint":false},{"year":2023,"finding":"SMSC-derived exosomal MATN3 suppresses activation of the PI3K/AKT/mTOR signaling pathway through IL-17A, protecting chondrocytes from ECM degradation and autophagy defects in an OA model.","method":"In vitro OA model (IL-1β), SMSC-Exo administration, overexpression and knockdown of MATN3, Western blot for PI3K/AKT/mTOR pathway components, in vivo mouse OA model (DMM surgery)","journal":"Journal of orthopaedic translation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single lab, in vitro and in vivo experiments with defined pathway readouts","pmids":["37635810"],"is_preprint":false},{"year":2024,"finding":"In gastric cancer, MATN3 interacts directly with ASPN (Co-IP/PPI analysis) and promotes cell proliferation, migration, and invasion; MATN3 knockdown inhibits these behaviors and induces apoptosis. Co-overexpression of MATN3 and ASPN in vivo enhances tumor growth and metastasis, indicating synergistic oncogenic activity through EMT pathway activation.","method":"Protein-protein interaction analysis, co-expression analysis, functional assays (proliferation, migration, invasion, apoptosis), in vivo xenograft mouse model","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single lab, multiple functional assays in vitro and in vivo, PPI confirmation, but mechanistic depth on EMT pathway is limited in the abstract","pmids":["39301785"],"is_preprint":false},{"year":2026,"finding":"GC-derived exosomal MATN3 interacts with EGFR (confirmed by Co-IP and co-localization by immunofluorescence), enhances EGFR protein stability, activates ELK1 transcription factor, which promotes ATG12-mediated autophagy activation, leading to M2 macrophage polarization and immunosuppressive tumor microenvironment. Mechanistic confirmation by ChIP, dual-luciferase reporter, ubiquitination assay.","method":"Co-IP, immunofluorescence co-localization, Western blot, RT-qPCR, ChIP assay, dual-luciferase reporter assay, ubiquitination assay, xenograft mouse model, co-culture of GC-Exo with macrophages","journal":"Immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single lab, multiple orthogonal mechanistic assays (Co-IP, ChIP, luciferase, ubiquitination), defined signaling axis, but not independently replicated","pmids":["42163458"],"is_preprint":false},{"year":2026,"finding":"In a human pluripotent stem cell (hPSC) model of MED with MATN3 mutations, mutant matrilin-3 causes upregulation of the cholesterol biosynthesis pathway and abnormal ECM matrix assembly, accompanied by distended ER, accumulation of lipid droplets, and increased cholesterol content in chondrocyte pellets. Some UPR marker gene expression was slightly increased.","method":"hPSC differentiation to chondrocytes, CRISPR-Cas9 gene editing and patient PBMC reprogramming, RNAseq, transmission electron microscopy, immunohistochemistry","journal":"Osteoarthritis and cartilage","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — hPSC model with CRISPR editing and patient-derived cells, multiple orthogonal methods (RNAseq, TEM, biochemistry), single lab","pmids":["41651153"],"is_preprint":false}],"current_model":"Matrilin-3 (MATN3) is a cartilage extracellular matrix protein with a vWFA (A) domain, four EGF repeats, and a coiled-coil region; disease-causing mutations in the A-domain cause its misfolding, retention in the rough ER associated with the chaperone ERp72, formation of non-native disulfide-bonded aggregates, and triggering of an unfolded protein response in chondrocytes—leading to reduced proliferation and dysregulated apoptosis in the growth plate and the skeletal dysplasia of MED—while secreted matrilin-3 participates in ECM assembly, and exosomal MATN3 can activate TGF-β/SMAD/AKT or EGFR/ELK1/ATG12 signaling in recipient cells."},"narrative":{"mechanistic_narrative":"MATN3 (matrilin-3) is a cartilage extracellular matrix protein built from a signal peptide, a von Willebrand factor A (vWFA/A) domain, four EGF repeats, and an alpha-helical coiled-coil region, expressed across cartilage types and by primary chondrocytes as a marker of the differentiated state [PMID:9799608]. In the matrix it binds type II and type IX collagen and participates in ECM assembly [PMID:18205203]. Dominant mutations clustered in the exon-2 A-domain, especially around the second beta-sheet, cause multiple epiphyseal dysplasia (MED) by misfolding the A-domain so that secretion is blocked and protein is retained intracellularly [PMID:16287128, PMID:15459972]; misfolded A-domains associate specifically with the ER chaperone ERp72 and accumulate in dilated rough ER cisternae [PMID:16287128]. In vivo, this retention triggers an unfolded protein response, reduces chondrocyte proliferation, and spatially dysregulates apoptosis in the growth plate, disrupting linear bone growth [PMID:17517694], with retained mutant protein forming non-native disulfide-bonded aggregates that co-retain matrilin-1 independently of normal hetero-oligomerization [PMID:22083516]. Beyond its structural ECM and disease role, MATN3 delivered via exosomes acts as a signaling ligand: it activates TGF-beta/SMAD/AKT signaling to promote nucleus pulposus proliferation and ECM synthesis [PMID:34136064], modulates the PI3K/AKT/mTOR axis through IL-17A to protect chondrocytes [PMID:37635810], and in gastric cancer drives proliferation and invasion through direct interaction with ASPN [PMID:39301785] and stabilization of EGFR with downstream ELK1/ATG12-mediated autophagy and M2 macrophage polarization [PMID:42163458].","teleology":[{"year":1998,"claim":"Establishing the protein architecture and expression pattern defined MATN3 as a chondrocyte-restricted ECM protein and a candidate differentiation marker.","evidence":"cDNA cloning from cartilage and Northern blot across primary vs. dedifferentiated chondrocytes","pmids":["9799608"],"confidence":"Medium","gaps":["No functional assay of the encoded protein","Role of individual domains not tested"]},{"year":2000,"claim":"Genomic characterization resolved the gene structure and showed MATN3 lacks the second vWFA domain present in other matrilins, distinguishing its architecture.","evidence":"Genomic cloning, exon mapping, and RNase protection in mouse","pmids":["10656920"],"confidence":"Medium","gaps":["Functional consequence of single vWFA domain not addressed","Splicing feature not linked to disease"]},{"year":2005,"claim":"Determining why MED mutations are pathogenic showed that A-domain misfolding blocks secretion and engages the ER chaperone ERp72, establishing a protein-retention disease mechanism.","evidence":"Mammalian secretion assays, reciprocal Co-IP with ERp72, EM and IHC of patient cartilage","pmids":["16287128"],"confidence":"High","gaps":["Did not establish downstream cellular consequences in vivo","Mechanism of ERp72-dependent retention not fully defined"]},{"year":2004,"claim":"Mutation mapping localized MED-causing changes to the exon-2 A-domain beta-sheet region, with one alpha-helix exception, defining the disease-critical region.","evidence":"PCR and direct sequencing of all MATN3 exons in MED patients","pmids":["15459972"],"confidence":"Medium","gaps":["No functional validation in this study","Genotype-phenotype correlation not resolved"]},{"year":2007,"claim":"An in vivo knock-in model connected mutant retention to a cellular pathology — UPR activation, reduced proliferation, and dysregulated apoptosis in the growth plate — explaining short-limbed dwarfism.","evidence":"Matn3 MED knock-in mouse with histology, IHC, EM, proliferation and apoptosis readouts","pmids":["17517694"],"confidence":"High","gaps":["Specific UPR effectors driving apoptosis not pinpointed","Therapeutic reversibility not tested"]},{"year":2008,"claim":"Testing individual A-domain mutations distinguished secretion-blocking from non-disruptive variants, showing not all helical mutations act through misfolding.","evidence":"In vitro A-domain secretion, structural assessment, and collagen-binding assays","pmids":["18205203"],"confidence":"Medium","gaps":["Disease mechanism of p.Lys231Asn unresolved","Single-lab in vitro readouts"]},{"year":2012,"claim":"Genetic epistasis clarified that mutant retention and aggregation are intrinsic to the misfolded A-domain, not dependent on matrilin-1 hetero-oligomerization.","evidence":"Matn3 V194D x Matn1-null cross with biochemical analysis of disulfide-bonded aggregates and phenotyping","pmids":["22083516"],"confidence":"High","gaps":["Aggregate clearance pathways not defined","Other matrilin partners not excluded"]},{"year":2021,"claim":"Identifying exosomal MATN3 as a signaling cargo revealed a non-structural role: it promotes nucleus pulposus proliferation and ECM synthesis via TGF-beta/SMAD/AKT activation.","evidence":"USC-exosome experiments with MATN3 knockdown, proliferation assays, signaling Western blots, and in vivo IDD model","pmids":["34136064"],"confidence":"Medium","gaps":["Receptor mediating MATN3-TGF-beta link not identified","Single lab"]},{"year":2023,"claim":"A second exosomal context showed MATN3 modulates the PI3K/AKT/mTOR axis through IL-17A to protect chondrocytes from ECM degradation and autophagy defects in OA.","evidence":"IL-1beta OA cell model, SMSC-Exo with MATN3 overexpression/knockdown, pathway Western blots, DMM in vivo model","pmids":["37635810"],"confidence":"Medium","gaps":["Direct MATN3 receptor not defined","Mechanistic link to IL-17A incomplete"]},{"year":2024,"claim":"In gastric cancer, MATN3 was shown to act as an oncogenic partner of ASPN, driving proliferation, migration, and invasion via EMT activation.","evidence":"PPI/Co-IP analysis, functional assays, and xenograft co-overexpression model","pmids":["39301785"],"confidence":"Medium","gaps":["EMT pathway mechanism only sketched","ASPN-MATN3 interaction interface unmapped"]},{"year":2026,"claim":"A defined gastric cancer signaling axis showed exosomal MATN3 stabilizes EGFR, activating ELK1-driven ATG12 autophagy and M2 macrophage polarization for immunosuppression.","evidence":"Co-IP, IF co-localization, ChIP, dual-luciferase, ubiquitination assays, xenograft and macrophage co-culture","pmids":["42163458"],"confidence":"Medium","gaps":["Not independently replicated","Mechanism of EGFR stabilization by MATN3 not fully resolved"]},{"year":2026,"claim":"A human iPSC MED model expanded the chondrocyte phenotype, linking mutant MATN3 to cholesterol biosynthesis upregulation and lipid droplet accumulation alongside abnormal ECM assembly.","evidence":"hPSC chondrocyte differentiation with CRISPR-edited and patient-derived cells, RNAseq, TEM, IHC","pmids":["41651153"],"confidence":"Medium","gaps":["Causal link between cholesterol changes and pathology not established","UPR induction only modest in this system"]},{"year":null,"claim":"How secreted/exosomal MATN3 engages specific cell-surface receptors to trigger TGF-beta, AKT/mTOR, and EGFR signaling, and whether these signaling roles relate mechanistically to its structural ECM function, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No defined MATN3 receptor for its signaling activities","Relationship between ECM-assembly role and exosomal signaling role unknown","Disease mechanism of non-secretion-blocking variants unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[4]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[2]}],"localization":[{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[2,4]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[4]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,1,3]}],"pathway":[{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[2,4]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,9,11]}],"complexes":[],"partners":["ERP72","MATN1","ASPN","EGFR","COL2A1","COL9A1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O15232","full_name":"Matrilin-3","aliases":[],"length_aa":486,"mass_kda":52.8,"function":"Major component of the extracellular matrix of cartilage and may play a role in the formation of extracellular filamentous networks","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/O15232/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MATN3","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MATN3","total_profiled":1310},"omim":[{"mim_id":"617895","title":"SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19","url":"https://www.omim.org/entry/617895"},{"mim_id":"609325","title":"EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES","url":"https://www.omim.org/entry/609325"},{"mim_id":"609324","title":"EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA","url":"https://www.omim.org/entry/609324"},{"mim_id":"608805","title":"AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1; ANFH1","url":"https://www.omim.org/entry/608805"},{"mim_id":"608728","title":"SPONDYLOEPIMETAPHYSEAL DYSPLASIA, BOROCHOWITZ-CORMIER-DAIRE TYPE; SEMDBCD","url":"https://www.omim.org/entry/608728"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Endoplasmic reticulum","reliability":"Approved"},{"location":"Golgi apparatus","reliability":"Approved"},{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"lung","ntpm":12.5},{"tissue":"placenta","ntpm":10.6}],"url":"https://www.proteinatlas.org/search/MATN3"},"hgnc":{"alias_symbol":["EDM5","HOA"],"prev_symbol":[]},"alphafold":{"accession":"O15232","domains":[{"cath_id":"3.40.50.410","chopping":"83-263","consensus_level":"high","plddt":88.6782,"start":83,"end":263},{"cath_id":"2.10.25.10","chopping":"266-308","consensus_level":"medium","plddt":81.4635,"start":266,"end":308},{"cath_id":"2.10.25","chopping":"320-350","consensus_level":"medium","plddt":86.2129,"start":320,"end":350},{"cath_id":"2.10.25.10","chopping":"353-392","consensus_level":"medium","plddt":84.92,"start":353,"end":392},{"cath_id":"2.10.25.10","chopping":"398-439","consensus_level":"medium","plddt":84.821,"start":398,"end":439}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O15232","model_url":"https://alphafold.ebi.ac.uk/files/AF-O15232-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O15232-F1-predicted_aligned_error_v6.png","plddt_mean":79.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MATN3","jax_strain_url":"https://www.jax.org/strain/search?query=MATN3"},"sequence":{"accession":"O15232","fasta_url":"https://rest.uniprot.org/uniprotkb/O15232.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O15232/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O15232"}},"corpus_meta":[{"pmid":"17517694","id":"PMC_17517694","title":"Decreased chondrocyte proliferation and dysregulated apoptosis in the cartilage growth plate are key features of a murine model of epiphyseal dysplasia caused by a matn3 mutation.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17517694","citation_count":66,"is_preprint":false},{"pmid":"16287128","id":"PMC_16287128","title":"Multiple epiphyseal dysplasia mutations in MATN3 cause misfolding of the A-domain and prevent secretion of mutant matrilin-3.","date":"2005","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/16287128","citation_count":65,"is_preprint":false},{"pmid":"34136064","id":"PMC_34136064","title":"Exosomal MATN3 of Urine-Derived Stem Cells Ameliorates Intervertebral Disc Degeneration by Antisenescence Effects and Promotes NPC Proliferation and ECM Synthesis by Activating TGF-β.","date":"2021","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/34136064","citation_count":63,"is_preprint":false},{"pmid":"15459972","id":"PMC_15459972","title":"Novel and recurrent mutations clustered in the von Willebrand factor A domain of MATN3 in multiple epiphyseal dysplasia.","date":"2004","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15459972","citation_count":47,"is_preprint":false},{"pmid":"14994237","id":"PMC_14994237","title":"Clinical and radiographic findings in multiple epiphyseal dysplasia caused by MATN3 mutations: description of 12 patients.","date":"2004","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/14994237","citation_count":42,"is_preprint":false},{"pmid":"9799608","id":"PMC_9799608","title":"Characterization of human matrilin-3 (MATN3).","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9799608","citation_count":35,"is_preprint":false},{"pmid":"37635810","id":"PMC_37635810","title":"MATN3 delivered by exosome from synovial mesenchymal stem cells relieves knee osteoarthritis: Evidence from in vitro and in vivo studies.","date":"2023","source":"Journal of orthopaedic translation","url":"https://pubmed.ncbi.nlm.nih.gov/37635810","citation_count":26,"is_preprint":false},{"pmid":"21965141","id":"PMC_21965141","title":"Revisit of multiple epiphyseal dysplasia: ethnic difference in genotypes and comparison of radiographic features linked to the COMP and MATN3 genes.","date":"2011","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/21965141","citation_count":23,"is_preprint":false},{"pmid":"18205203","id":"PMC_18205203","title":"Novel mutations in exon 2 of MATN3 affect residues within the alpha-helices of the A-domain and can result in the intracellular retention of mutant matrilin-3.","date":"2008","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/18205203","citation_count":18,"is_preprint":false},{"pmid":"34564536","id":"PMC_34564536","title":"Use of Essential Oils for the Control of Anthracnose Disease Caused by Colletotrichum acutatum on Post-Harvest Mangoes of Cat Hoa Loc Variety.","date":"2021","source":"Membranes","url":"https://pubmed.ncbi.nlm.nih.gov/34564536","citation_count":17,"is_preprint":false},{"pmid":"10656920","id":"PMC_10656920","title":"Structure and mapping of the mouse matrilin-3 gene (Matn3), a member of a gene family containing a U12-type AT-AC intron.","date":"2000","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/10656920","citation_count":15,"is_preprint":false},{"pmid":"30080953","id":"PMC_30080953","title":"Alu-Alu mediated intragenic duplications in IFT81 and MATN3 are associated with skeletal dysplasias.","date":"2018","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/30080953","citation_count":15,"is_preprint":false},{"pmid":"24629099","id":"PMC_24629099","title":"Comparison of orthopaedic manifestations of multiple epiphyseal dysplasia caused by MATN3 versus COMP mutations: a case control study.","date":"2014","source":"BMC musculoskeletal disorders","url":"https://pubmed.ncbi.nlm.nih.gov/24629099","citation_count":13,"is_preprint":false},{"pmid":"33489760","id":"PMC_33489760","title":"Hereditary orotic aciduria (HOA): A novel uridine-5-monophosphate synthase (UMPS) mutation.","date":"2021","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/33489760","citation_count":11,"is_preprint":false},{"pmid":"35351166","id":"PMC_35351166","title":"hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of 'MET-addicted' cancers.","date":"2022","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/35351166","citation_count":10,"is_preprint":false},{"pmid":"22083516","id":"PMC_22083516","title":"Loss of matrilin 1 does not exacerbate the skeletal phenotype in a mouse model of multiple epiphyseal dysplasia caused by a Matn3 V194D mutation.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/22083516","citation_count":9,"is_preprint":false},{"pmid":"33056646","id":"PMC_33056646","title":"Two new species of Hemiphyllodactylus (Squamata: Gekkonidae) from Hoa Binh Province, Vietnam.","date":"2020","source":"Zootaxa","url":"https://pubmed.ncbi.nlm.nih.gov/33056646","citation_count":9,"is_preprint":false},{"pmid":"29468891","id":"PMC_29468891","title":"Two new prenylated isoflavones from Maclura cochinchinensis collected in Hoa Binh province Vietnam.","date":"2018","source":"Natural product research","url":"https://pubmed.ncbi.nlm.nih.gov/29468891","citation_count":9,"is_preprint":false},{"pmid":"22270056","id":"PMC_22270056","title":"A haplotype of MATN3 is associated with vertebral fracture in Chinese postmenopausal women: Peking Vertebral Fracture (PK-VF) study.","date":"2012","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/22270056","citation_count":8,"is_preprint":false},{"pmid":"26438923","id":"PMC_26438923","title":"Sarcophaga (Hoa)flexuosa Ho (Diptera: Sarcophagidae): association of sexes using morphological and molecular approaches, and a redefinition of Hoa Rohdendorf.","date":"2013","source":"Zootaxa","url":"https://pubmed.ncbi.nlm.nih.gov/26438923","citation_count":8,"is_preprint":false},{"pmid":"30036799","id":"PMC_30036799","title":"Characterization of the mature form of a β-defensin-like peptide, Hoa-D1, in the lobster Homarus americanus.","date":"2018","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30036799","citation_count":7,"is_preprint":false},{"pmid":"24865837","id":"PMC_24865837","title":"Hair-inspired crystal growth of HOA in cavities of cellulose matrix via hydrophobic-hydrophilic interface interaction.","date":"2014","source":"ACS applied materials & interfaces","url":"https://pubmed.ncbi.nlm.nih.gov/24865837","citation_count":7,"is_preprint":false},{"pmid":"22973175","id":"PMC_22973175","title":"MATN3 gene polymorphism is associated with osteoarthritis in Chinese Han population: a community-based case-control study.","date":"2012","source":"TheScientificWorldJournal","url":"https://pubmed.ncbi.nlm.nih.gov/22973175","citation_count":6,"is_preprint":false},{"pmid":"31378748","id":"PMC_31378748","title":"Endophytic actinomycetes associated with Cinnamomum cassia Presl in Hoa Binh province, Vietnam: Distribution, antimicrobial activity and, genetic features.","date":"2019","source":"The Journal of general and applied microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31378748","citation_count":6,"is_preprint":false},{"pmid":"39353384","id":"PMC_39353384","title":"Amino acid metabolism-related genes as potential biomarkers and the role of MATN3 in stomach adenocarcinoma: A bioinformatics, mendelian randomization and experimental validation study.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39353384","citation_count":5,"is_preprint":false},{"pmid":"34144599","id":"PMC_34144599","title":"Mosquitoes (Diptera: Culicidae) from Villages and Forest Areas of Rural Communes in Khanh Hoa and Binh Phuoc Provinces, Vietnam.","date":"2021","source":"Journal of medical entomology","url":"https://pubmed.ncbi.nlm.nih.gov/34144599","citation_count":4,"is_preprint":false},{"pmid":"39301785","id":"PMC_39301785","title":"Investigating MATN3 and ASPN as novel drivers of gastric cancer progression via EMT pathways.","date":"2024","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39301785","citation_count":3,"is_preprint":false},{"pmid":"25087452","id":"PMC_25087452","title":"Public health assessment of dioxin-contaminated fish at former US airbase, Bien Hoa, Vietnam.","date":"2014","source":"International journal of environmental health research","url":"https://pubmed.ncbi.nlm.nih.gov/25087452","citation_count":2,"is_preprint":false},{"pmid":"41004439","id":"PMC_41004439","title":"Regulatory influence of α-Pinene on MATN3 expression in hepatocellular carcinoma: Extending to pan-cancer analysis.","date":"2025","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/41004439","citation_count":0,"is_preprint":false},{"pmid":"42163458","id":"PMC_42163458","title":"Gastric Cancer-Derived Exosomal MATN3 Favours Immunosuppressive Tumour Microenvironment by Activating Autophagy in an EGFR/ELK1/ATG12 Signalling Dependent Manner.","date":"2026","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/42163458","citation_count":0,"is_preprint":false},{"pmid":"41651153","id":"PMC_41651153","title":"Human pluripotent stem cell model of multiple epiphyseal dysplasia with MATN3 mutation identifies altered matrix organisation and upregulation of the cholesterol biosynthesis pathway.","date":"2026","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/41651153","citation_count":0,"is_preprint":false},{"pmid":"38470099","id":"PMC_38470099","title":"Comparison of waist circumference and waist-to-height ratio as predictors of clustering of cardiovascular risk factors among middle-aged people in rural Khanh Hoa, Vietnam.","date":"2024","source":"American journal of human biology : the official journal of the Human Biology Council","url":"https://pubmed.ncbi.nlm.nih.gov/38470099","citation_count":0,"is_preprint":false},{"pmid":"41036007","id":"PMC_41036007","title":"Phylogenetic analysis of swine influenza viruses circulating in slaughterhouses in Thanh Hoa province, Vietnam, during 2024 and early 2025.","date":"2025","source":"Open veterinary journal","url":"https://pubmed.ncbi.nlm.nih.gov/41036007","citation_count":0,"is_preprint":false},{"pmid":"41048848","id":"PMC_41048848","title":"A new species of Cyrtodactylus (Squamata, Gekkonidae) from Hon Tre Island in Khanh Hoa Province, Vietnam.","date":"2025","source":"ZooKeys","url":"https://pubmed.ncbi.nlm.nih.gov/41048848","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.01.673425","title":"Human pluripotent stem cell model of multiple epiphyseal dysplasia with  <i>MATN3</i>  mutation identifies altered Matrix organisation and upregulation of the cholesterol biosynthesis pathway","date":"2025-09-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.01.673425","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21040,"output_tokens":3517,"usd":0.057938,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11092,"output_tokens":3678,"usd":0.073705,"stage2_stop_reason":"end_turn"},"total_usd":0.131643,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"MED-causing MATN3 mutations in the A-domain cause misfolding of that domain (shown by unfolded conformation of mutant A-domains expressed individually) and prevent secretion of matrilin-3 from mammalian cells; mutant protein is retained intracellularly. Co-immunoprecipitation demonstrated that mutant A-domains associate specifically with ERp72, an ER chaperone involved in disulfide bond formation. Electron microscopy of patient cartilage confirmed intracellular retention in dilated rough ER cisternae.\",\n      \"method\": \"Mammalian cell expression of wild-type and mutant matrilin-3, co-immunoprecipitation with ERp72, electron microscopy and immunohistochemistry of patient cartilage\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, multiple orthogonal methods (cell secretion assay, structural analysis of isolated domain, EM of patient tissue), replicated in subsequent studies\",\n      \"pmids\": [\"16287128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In a knock-in mouse model carrying a Matn3 MED mutation, mutant matrilin-3 is retained within the rough ER of chondrocytes and triggers an unfolded protein response (UPR), leading to decreased chondrocyte proliferation and spatially dysregulated apoptosis in the cartilage growth plate, which disrupts linear bone growth and causes short-limbed dwarfism.\",\n      \"method\": \"Mouse knock-in model, histochemistry, immunohistochemistry, electron microscopy, assessment of chondrocyte proliferation and apoptosis in growth plate\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knock-in model with multiple orthogonal cellular readouts (UPR, proliferation, apoptosis), consistent with in vitro findings from multiple labs\",\n      \"pmids\": [\"17517694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Two alpha-helical A-domain mutations (p.Phe105Ser and p.Ala173Asp) prevent secretion of matrilin-3 A-domain in vitro, similar to beta-sheet mutations. However, a third alpha-helical mutation (p.Lys231Asn) does not prevent A-domain secretion, does not disrupt A-domain structure, and does not inhibit binding to type II or type IX collagen, leaving its disease mechanism unresolved.\",\n      \"method\": \"In vitro A-domain expression and secretion assay, structural assessment, collagen binding assay\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single lab, multiple assays (secretion, structural, collagen binding), clear positive and negative findings distinguished\",\n      \"pmids\": [\"18205203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Secretion of mutant matrilin-3 (V194D) is not dependent on hetero-oligomerization with matrilin-1; ablation of matrilin-1 expression in Matn3 V194D mice does not alter the proportion of mutant matrilin-3 in the ECM, does not increase intracellular retention, and does not worsen disease severity. Retained mutant matrilin-3 forms non-native disulfide-bonded aggregates through the misfolded A-domain and causes co-retention of matrilin-1.\",\n      \"method\": \"Genetic cross of Matn3 V194D knock-in with Matn1-null mice; histochemistry, biochemistry (disulfide-bonded aggregate analysis), phenotypic assessment\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo double-mutant genetic epistasis, biochemical characterization of aggregates, multiple orthogonal methods, clear negative and positive findings\",\n      \"pmids\": [\"22083516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Human MATN3 encodes a 486 amino acid extracellular matrix protein with the domain architecture: signal peptide, von Willebrand factor A (vWFA) domain, four EGF repeats, and an alpha-helical coiled-coil region. The mRNA is expressed in all cartilage types and by primary (but not dedifferentiated) chondrocytes, suggesting matrilin-3 as a marker of chondrocyte differentiation state.\",\n      \"method\": \"cDNA cloning from cartilage library, sequence analysis, Northern blot / expression in primary vs. dedifferentiated chondrocytes\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — structural characterization from cDNA, cell biology of expression in differentiation states; foundational characterization paper\",\n      \"pmids\": [\"9799608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The mouse Matn3 gene comprises 8 exons spanning 23.4 kb; the last intron uses non-canonical AT-AC ends and is spliced by the U12-type spliceosome, a feature conserved in all matrilin genes. Unlike other matrilins, Matn3 lacks a second vWFA domain; the intron that could encode it contains 75% repetitive sequences indicating evolutionary loss.\",\n      \"method\": \"Genomic cloning, exon mapping, RNase protection assay for transcription start sites, SSCP mapping\",\n      \"journal\": \"Mammalian genome\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct genomic and structural characterization, single lab, well-defined methods\",\n      \"pmids\": [\"10656920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"All characterized MED-causing MATN3 mutations cluster within exon 2 encoding the vWFA (A) domain, specifically in and around the 2nd beta-sheet region (amino acids 120-127). One novel mutation (p.F105S) extends the affected region to an alpha-helix of the A-domain, outside the beta-sheet.\",\n      \"method\": \"PCR and direct sequencing of all 8 MATN3 exons in MED patients\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — mutation mapping by sequencing in multiple unrelated families, consistent with parallel studies, but no functional assay in this paper\",\n      \"pmids\": [\"15459972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"An intragenic de novo tandem duplication of exons 2–5 in MATN3 (formed via Alu-Alu mediated recombination) causes multiple epiphyseal dysplasia, establishing intragenic CNV as a novel mutational mechanism for MATN3-related disease.\",\n      \"method\": \"Targeted CNV screening, breakpoint characterization (Alu-Alu fusion identification)\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single case, structural/genetic characterization only, no functional assay for MATN3 protein\",\n      \"pmids\": [\"30080953\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Exosomal MATN3 protein from urine-derived stem cells promotes nucleus pulposus cell (NPC) proliferation and ECM synthesis, and alleviates intervertebral disc degeneration in vivo. The mechanism involves MATN3 activating TGF-β signaling, elevating phosphorylation of SMAD and AKT. MATN3 was identified as the required cargo mediating these USC-exosome effects by knockdown experiments.\",\n      \"method\": \"Western blot, CCK-8 proliferation assay, immunofluorescence, in vivo IDD mouse model (CT, MRI, histology), MATN3 knockdown in exosomes\",\n      \"journal\": \"Oxidative medicine and cellular longevity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single lab, multiple orthogonal methods (in vitro knockdown, in vivo rescue), defined signaling readout (SMAD/AKT phosphorylation)\",\n      \"pmids\": [\"34136064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SMSC-derived exosomal MATN3 suppresses activation of the PI3K/AKT/mTOR signaling pathway through IL-17A, protecting chondrocytes from ECM degradation and autophagy defects in an OA model.\",\n      \"method\": \"In vitro OA model (IL-1β), SMSC-Exo administration, overexpression and knockdown of MATN3, Western blot for PI3K/AKT/mTOR pathway components, in vivo mouse OA model (DMM surgery)\",\n      \"journal\": \"Journal of orthopaedic translation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single lab, in vitro and in vivo experiments with defined pathway readouts\",\n      \"pmids\": [\"37635810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In gastric cancer, MATN3 interacts directly with ASPN (Co-IP/PPI analysis) and promotes cell proliferation, migration, and invasion; MATN3 knockdown inhibits these behaviors and induces apoptosis. Co-overexpression of MATN3 and ASPN in vivo enhances tumor growth and metastasis, indicating synergistic oncogenic activity through EMT pathway activation.\",\n      \"method\": \"Protein-protein interaction analysis, co-expression analysis, functional assays (proliferation, migration, invasion, apoptosis), in vivo xenograft mouse model\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single lab, multiple functional assays in vitro and in vivo, PPI confirmation, but mechanistic depth on EMT pathway is limited in the abstract\",\n      \"pmids\": [\"39301785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"GC-derived exosomal MATN3 interacts with EGFR (confirmed by Co-IP and co-localization by immunofluorescence), enhances EGFR protein stability, activates ELK1 transcription factor, which promotes ATG12-mediated autophagy activation, leading to M2 macrophage polarization and immunosuppressive tumor microenvironment. Mechanistic confirmation by ChIP, dual-luciferase reporter, ubiquitination assay.\",\n      \"method\": \"Co-IP, immunofluorescence co-localization, Western blot, RT-qPCR, ChIP assay, dual-luciferase reporter assay, ubiquitination assay, xenograft mouse model, co-culture of GC-Exo with macrophages\",\n      \"journal\": \"Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single lab, multiple orthogonal mechanistic assays (Co-IP, ChIP, luciferase, ubiquitination), defined signaling axis, but not independently replicated\",\n      \"pmids\": [\"42163458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In a human pluripotent stem cell (hPSC) model of MED with MATN3 mutations, mutant matrilin-3 causes upregulation of the cholesterol biosynthesis pathway and abnormal ECM matrix assembly, accompanied by distended ER, accumulation of lipid droplets, and increased cholesterol content in chondrocyte pellets. Some UPR marker gene expression was slightly increased.\",\n      \"method\": \"hPSC differentiation to chondrocytes, CRISPR-Cas9 gene editing and patient PBMC reprogramming, RNAseq, transmission electron microscopy, immunohistochemistry\",\n      \"journal\": \"Osteoarthritis and cartilage\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — hPSC model with CRISPR editing and patient-derived cells, multiple orthogonal methods (RNAseq, TEM, biochemistry), single lab\",\n      \"pmids\": [\"41651153\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Matrilin-3 (MATN3) is a cartilage extracellular matrix protein with a vWFA (A) domain, four EGF repeats, and a coiled-coil region; disease-causing mutations in the A-domain cause its misfolding, retention in the rough ER associated with the chaperone ERp72, formation of non-native disulfide-bonded aggregates, and triggering of an unfolded protein response in chondrocytes—leading to reduced proliferation and dysregulated apoptosis in the growth plate and the skeletal dysplasia of MED—while secreted matrilin-3 participates in ECM assembly, and exosomal MATN3 can activate TGF-β/SMAD/AKT or EGFR/ELK1/ATG12 signaling in recipient cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MATN3 (matrilin-3) is a cartilage extracellular matrix protein built from a signal peptide, a von Willebrand factor A (vWFA/A) domain, four EGF repeats, and an alpha-helical coiled-coil region, expressed across cartilage types and by primary chondrocytes as a marker of the differentiated state [#4]. In the matrix it binds type II and type IX collagen and participates in ECM assembly [#2]. Dominant mutations clustered in the exon-2 A-domain, especially around the second beta-sheet, cause multiple epiphyseal dysplasia (MED) by misfolding the A-domain so that secretion is blocked and protein is retained intracellularly [#0, #6]; misfolded A-domains associate specifically with the ER chaperone ERp72 and accumulate in dilated rough ER cisternae [#0]. In vivo, this retention triggers an unfolded protein response, reduces chondrocyte proliferation, and spatially dysregulates apoptosis in the growth plate, disrupting linear bone growth [#1], with retained mutant protein forming non-native disulfide-bonded aggregates that co-retain matrilin-1 independently of normal hetero-oligomerization [#3]. Beyond its structural ECM and disease role, MATN3 delivered via exosomes acts as a signaling ligand: it activates TGF-beta/SMAD/AKT signaling to promote nucleus pulposus proliferation and ECM synthesis [#8], modulates the PI3K/AKT/mTOR axis through IL-17A to protect chondrocytes [#9], and in gastric cancer drives proliferation and invasion through direct interaction with ASPN [#10] and stabilization of EGFR with downstream ELK1/ATG12-mediated autophagy and M2 macrophage polarization [#11].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing the protein architecture and expression pattern defined MATN3 as a chondrocyte-restricted ECM protein and a candidate differentiation marker.\",\n      \"evidence\": \"cDNA cloning from cartilage and Northern blot across primary vs. dedifferentiated chondrocytes\",\n      \"pmids\": [\"9799608\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional assay of the encoded protein\", \"Role of individual domains not tested\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Genomic characterization resolved the gene structure and showed MATN3 lacks the second vWFA domain present in other matrilins, distinguishing its architecture.\",\n      \"evidence\": \"Genomic cloning, exon mapping, and RNase protection in mouse\",\n      \"pmids\": [\"10656920\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of single vWFA domain not addressed\", \"Splicing feature not linked to disease\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Determining why MED mutations are pathogenic showed that A-domain misfolding blocks secretion and engages the ER chaperone ERp72, establishing a protein-retention disease mechanism.\",\n      \"evidence\": \"Mammalian secretion assays, reciprocal Co-IP with ERp72, EM and IHC of patient cartilage\",\n      \"pmids\": [\"16287128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish downstream cellular consequences in vivo\", \"Mechanism of ERp72-dependent retention not fully defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mutation mapping localized MED-causing changes to the exon-2 A-domain beta-sheet region, with one alpha-helix exception, defining the disease-critical region.\",\n      \"evidence\": \"PCR and direct sequencing of all MATN3 exons in MED patients\",\n      \"pmids\": [\"15459972\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional validation in this study\", \"Genotype-phenotype correlation not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"An in vivo knock-in model connected mutant retention to a cellular pathology — UPR activation, reduced proliferation, and dysregulated apoptosis in the growth plate — explaining short-limbed dwarfism.\",\n      \"evidence\": \"Matn3 MED knock-in mouse with histology, IHC, EM, proliferation and apoptosis readouts\",\n      \"pmids\": [\"17517694\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific UPR effectors driving apoptosis not pinpointed\", \"Therapeutic reversibility not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Testing individual A-domain mutations distinguished secretion-blocking from non-disruptive variants, showing not all helical mutations act through misfolding.\",\n      \"evidence\": \"In vitro A-domain secretion, structural assessment, and collagen-binding assays\",\n      \"pmids\": [\"18205203\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Disease mechanism of p.Lys231Asn unresolved\", \"Single-lab in vitro readouts\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Genetic epistasis clarified that mutant retention and aggregation are intrinsic to the misfolded A-domain, not dependent on matrilin-1 hetero-oligomerization.\",\n      \"evidence\": \"Matn3 V194D x Matn1-null cross with biochemical analysis of disulfide-bonded aggregates and phenotyping\",\n      \"pmids\": [\"22083516\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Aggregate clearance pathways not defined\", \"Other matrilin partners not excluded\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying exosomal MATN3 as a signaling cargo revealed a non-structural role: it promotes nucleus pulposus proliferation and ECM synthesis via TGF-beta/SMAD/AKT activation.\",\n      \"evidence\": \"USC-exosome experiments with MATN3 knockdown, proliferation assays, signaling Western blots, and in vivo IDD model\",\n      \"pmids\": [\"34136064\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor mediating MATN3-TGF-beta link not identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"A second exosomal context showed MATN3 modulates the PI3K/AKT/mTOR axis through IL-17A to protect chondrocytes from ECM degradation and autophagy defects in OA.\",\n      \"evidence\": \"IL-1beta OA cell model, SMSC-Exo with MATN3 overexpression/knockdown, pathway Western blots, DMM in vivo model\",\n      \"pmids\": [\"37635810\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct MATN3 receptor not defined\", \"Mechanistic link to IL-17A incomplete\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"In gastric cancer, MATN3 was shown to act as an oncogenic partner of ASPN, driving proliferation, migration, and invasion via EMT activation.\",\n      \"evidence\": \"PPI/Co-IP analysis, functional assays, and xenograft co-overexpression model\",\n      \"pmids\": [\"39301785\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"EMT pathway mechanism only sketched\", \"ASPN-MATN3 interaction interface unmapped\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"A defined gastric cancer signaling axis showed exosomal MATN3 stabilizes EGFR, activating ELK1-driven ATG12 autophagy and M2 macrophage polarization for immunosuppression.\",\n      \"evidence\": \"Co-IP, IF co-localization, ChIP, dual-luciferase, ubiquitination assays, xenograft and macrophage co-culture\",\n      \"pmids\": [\"42163458\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Not independently replicated\", \"Mechanism of EGFR stabilization by MATN3 not fully resolved\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"A human iPSC MED model expanded the chondrocyte phenotype, linking mutant MATN3 to cholesterol biosynthesis upregulation and lipid droplet accumulation alongside abnormal ECM assembly.\",\n      \"evidence\": \"hPSC chondrocyte differentiation with CRISPR-edited and patient-derived cells, RNAseq, TEM, IHC\",\n      \"pmids\": [\"41651153\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal link between cholesterol changes and pathology not established\", \"UPR induction only modest in this system\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How secreted/exosomal MATN3 engages specific cell-surface receptors to trigger TGF-beta, AKT/mTOR, and EGFR signaling, and whether these signaling roles relate mechanistically to its structural ECM function, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No defined MATN3 receptor for its signaling activities\", \"Relationship between ECM-assembly role and exosomal signaling role unknown\", \"Disease mechanism of non-secretion-blocking variants unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [2, 4]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 1, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [2, 4]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 9, 11]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ERp72\", \"MATN1\", \"ASPN\", \"EGFR\", \"COL2A1\", \"COL9A1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}